Medtronic set 4.5939 ratio as Medtronic stock costs EUR 78.99

Published on 10/12/2026 at 09:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MiniMed offer covers 225,361,295 shares on October 7, 2026. Medtronic stock costs EUR 78.99 on October 12, 2026, 0.91 percent above EUR 78.28.

Key points in brief

Medtronic set a final MiniMed exchange ratio of 4.5939 shares for each accepted Medtronic share on October 7, 2026.
The offer covers 225,361,295 MiniMed shares and followed the September 14 launch of the separation process.
Fiscal first-quarter 2027 revenue reached USD 9.756 billion, up 13.70 percent year over year.
Medtronic stock was EUR 78.99 at Lang & Schwarz on October 12, 2026, up 0.91 percent versus the Xetra close of October 9, 2026.
The company trades on the NYSE under MDT and is included in the S&P 500.

Pop-Art-Comic eines Chirurgen bei robotergestützter Operation in kräftigen Farben — Medtronic plc (ISIN IE00BTN1Y115) Pop-Art-Comic zeigt Chirurg bei robotergestützter Operation mit kräftigen Farben, Illustration mit AI erstellt.

Medtronic plc (ISIN IE00BTN1Y115) set a final exchange ratio of 4.5939 MiniMed shares for each accepted Medtronic share on October 7, 2026, according to Medtronic. The stock was EUR 78.99 at Lang & Schwarz on October 12, 2026, up 0.91 percent against the Xetra close of October 9, 2026 at EUR 78.28.

Three steps shaped the separation

On September 14, 2026, Medtronic launched the exchange offer for at least 80.10 percent of MiniMed, with the terms published by PR Newswire. On September 1, 2026, fiscal first-quarter revenue reached USD 9.756 billion, up 13.70 percent year over year, while adjusted earnings per share came to USD 1.45, according to Yahoo Finance.

On October 7, 2026, the final ratio reached the contractual cap of 4.5939. The offer covers 225,361,295 MiniMed shares, while Medtronic said the exchange could include another 27,452,053 shares if demand exceeds the initial amount, according to Medtronic.

What does the offer change?

The transaction shifts the Diabetes business toward a separate public listing while leaving the exchange mechanics dependent on valid tenders and possible proration. That makes the 4.5939 ratio more important than the headline share count for holders evaluating the separation.

Revenue gives the stock a second anchor

Medtronic's fiscal first-quarter 2027 revenue of USD 9.756 billion exceeded the USD 9.55 billion consensus cited by Yahoo Finance. The same period produced adjusted earnings per share of USD 1.45 versus USD 1.39 expected, although the quarter included an extra selling week that contributed USD 570 million of revenue.

The next reported event is scheduled for November 24, 2026, according to TradingView. The date gives the market a clear checkpoint for whether the separation and the broader revenue trend continue to support the higher fiscal 2027 outlook.

Stock holds above the Xetra close

At EUR 78.99, Medtronic stock was 0.91 percent above the Xetra close of October 9, 2026 at EUR 78.28, with the Lang & Schwarz quote timestamped at 9:11 a.m. CEST on October 12, 2026. Its market capitalization was USD 113.3 billion, while the 52-week range was USD 73.31 to USD 106.33 as of October 9, 2026.

The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.